CRISPR Therapeutics
@CRISPRTX
Followers
23K
Following
11
Media
271
Statuses
436
Joined December 2014
We're proud to be named on @TIME's Most Influential Companies of 2025 list – a recognition for our work toward bringing genetic medicines to people suffering from serious diseases on a global scale. Congrats to all the #TIME100Companies!
3
12
53
Today, we announced updates across our in vivo cardiovascular programs, which include new data for CTX310 (targeting ANGPTL3) as well as continued progress on CTX320 (targeting the LPA gene) and CTX340 (targeting the AGT gene):
5
12
74
On #WorldSickleCellDay, we #ShinetheLightonSickleCell and raise awareness about the impact of #SickleCellDisease. Learn more about #SCD here:
2
4
30
Meet Keturah, an individual living with #TCellLymphoma. From her long journey to diagnosis, to her role as an advocate for the T cell lymphoma community, Keturah's story continues to inspire us. Read her story here:
2
3
20
Today, we announced a collaboration with Sirius Tx to co-develop SRSD107, a next generation, long-acting Factor XI siRNA for the treatment of thromboembolic disorders. This will expand our cardiovascular portfolio and broaden our therapeutic toolkit.
6
14
89
May is #LupusAwarenessMonth and today is #WorldLupusDay. This month, the community comes together to raise awareness about #lupus and its impact on many facets of life. Learn more about this awareness month at @LupusOrg's website:
1
5
13
Today is #WorldThalassemiaDay. #Thalassemia is a #blooddisorder where the body does not make enough hemoglobin, which carries oxygen to the cells in the body. Today, we raise awareness for this condition. Learn more about it here:
1
2
18
The #TIME100HEALTH 2025 list features inspiring trailblazers who are reshaping the future of healthcare. Congrats to our CEO & Chairman @CrisprSam on being named to the list, and congrats to all the honorees. Read the full list here:
3
1
26
#NationalCancerResearchMonth is an awareness campaign initiated and supported by the @AACR. We are proud to recognize this initiative, which highlights the importance of innovative cancer research. Learn more here:
3
1
21
March 24th is Lipoprotein(a) Awareness Day, an initiative by the @FamilyHeartFdn. This day aims to raise awareness of elevated Lipoprotein(a), also known as Lp(a), as an under-recognized cause of premature heart disease and stroke. Learn more at: #KnowLpa
2
0
15
Today, we announced our fourth quarter and full year earnings results. Read more about our recent highlights and outlook:
11
8
58
We are pleased to invite Briggs Morrison, M.D., to join our Board of Directors. His extensive experience in the pharmaceutical industry and expertise in clinical development will be invaluable as we continue advancing our platform and pipeline. Learn more:
4
8
60
We’re proud to have presented our latest findings at #ASH24. Thank you to our team for their hard work, dedication, and collaboration in making this possible. It’s inspiring to share progress and innovation with the scientific community as we continue advancing our programs.
7
6
67
We’re pleased to share an update on our ongoing Phase 1/2 dose escalation clinical trial evaluating the safety & efficacy of CTX112™, a next-generation CD19 allogeneic CAR T cell therapy, in relapsed or refractory CD19-positive B-cell malignancies: #ASH24
2
18
81
We are thrilled that the 2024 Scrip Awards recognized our pioneering work and innovation in drug discovery and development for patients. Congratulations to all the winners across categories! #ScripAwards
4
4
37
